BioSpace News Archive

Aura Biosciences, a leader in the development of novel targeted therapies in ocular oncology, announced that members of Aura’s executive team will participate in the following upcoming investor conferences

Bicycle Therapeutics plc announced that management will present at the Canaccord Genuity 39th Annual Growth Conference on Wednesday, August 7, 2019 at 1:30 p.m. EDT in Boston, MA.

Aimmune Therapeutics, Inc., a biopharmaceutical company developing treatments for life-threatening food allergies, announced that it will host a conference call on Thursday, August 8, 2019, at 4:30 p.m. ET to discuss its financial results for the quarter ended June 30, 2019, and recent operational highlights.

ZDNet and Nucleus Research also name Veeva a leader for continued innovation in Veeva CRM

Abiomed, Inc. reported first quarter fiscal 2020 revenue of $207.7 million, an increase of 15.4% compared to revenue of $180.0 million for the same period of fiscal 2019.

Seres Therapeutics, Inc. announced that it will present at the Canaccord Genuity 39th Annual Growth Conference in Boston, MA on Wednesday, August 7 at 8:00 a.m. ET.

IVERIC bio, Inc. announced financial and operating results for the second quarter ended June 30, 2019 and provided a business update.

Sepsis tests will be developed in collaboration with the Cincinnati Children’s Hospital Medical Center (CCHMC) and The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) to address the critical need for more effective sepsis patient management in clinical and field settings

Insmed Incorporated, a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, reported financial results for the second quarter ended June 30, 2019 and provided a business update.

Intrexon Corporation announced it will release second quarter and first half 2019 financial results after the market closes on Thursday, August 8th, 2019.